Women's Health Innovation Series: Fertility Innovation Summit 2021

Women's Health Innovation Series: Fertility Innovation Summit

Empowering women’s understanding of their own reproductive health through education, advanced clinical research, and innovative technology.

Download the agenda
VIRTUAL SUMMIT | EST Timezone
20 April, 2021

Do you have an innovative product or service that supports people in their fertility journeys? Apply today for the innovation spotlight to showcase your product to the entire Fertility Innovation Summit

WHY ATTEND?

Women’s health today is under-served from innovation and clinical science standpoints with outdated practices and lack of much-needed attention from key players (incl. investors and insurers). It is imperative to develop the eco-system, shift mindsets and embrace a holistic, women-centered approach.

As part of our leading Women’s Health Innovation Series, The Fertility Innovation Summit is the second instalment of our 1-day themed events throughout 2021. Take a deep-dive into the verticals that are driving change in women’s health to improve the quality and access to healthcare for women globally. 

Reproductive-health-supporting technologies and research advances are on the rise. The Fertility Innovation Summit will focus on how to harness such innovation’s through partnerships, investment, and collaborations to empower women’s understanding and control over their own reproductive health. The breadth of advancements in fertility will be explored from clinical research, to mental health challenges, to the role of technology and digitization to determine next steps for the continued growth of this industry.

Join our leading network of biotech, medical device companies, start-ups, insurers, investors, pharma, researchers, and HCPs to drive innovation at the convergence of healthcare and technology.

WHIS Steering Committee 2021

Author:

Maryjane Lacoste

Senior Program Officer for Family Planning Service Delivery and Quality
Bill and Melinda Gates Foundation

Maryjane Lacoste joined The Bill and Melinda Gates Foundation in May 2014, working with the Family Planning Team as the Senior Program Officer for Family Planning Service Delivery and Quality.  As such, she led the implementation of the Implant Access Program and currently leads and manages the DMPA-SC introduction/scale portfolio, ensuring that the strategy focuses on expanding access to method choice and strengthens quality of care including counseling, interpersonal communications, clinical training, service delivery and performance monitoring.  She also oversees the family planning portfolio in Indonesia and guides on postpartum and postabortion FP strategies.  Prior to joining the Foundation, Maryjane worked with Jhpiego for over 20 years, spending the last 15 years in the field as country/regional director in Tanzania, Indonesia and Malawi.  She has worked with Ministries of Health, donors and other stakeholders to develop and manage implementation of large reproductive health, maternal, newborn and child health and HIV projects in many countries in sub-Saharan Africa, as well as in Indonesia. Maryjane holds a Master of Arts degree from University of Maryland and a Bachelor of Arts degree from Loyola University.

Maryjane Lacoste

Senior Program Officer for Family Planning Service Delivery and Quality
Bill and Melinda Gates Foundation

Maryjane Lacoste joined The Bill and Melinda Gates Foundation in May 2014, working with the Family Planning Team as the Senior Program Officer for Family Planning Service Delivery and Quality.  As such, she led the implementation of the Implant Access Program and currently leads and manages the DMPA-SC introduction/scale portfolio, ensuring that the strategy focuses on expanding access to method choice and strengthens quality of care including counseling, interpersonal communications, clinical training, service delivery and performance monitoring.  She also oversees the family planning portfolio in Indonesia and guides on postpartum and postabortion FP strategies.  Prior to joining the Foundation, Maryjane worked with Jhpiego for over 20 years, spending the last 15 years in the field as country/regional director in Tanzania, Indonesia and Malawi.  She has worked with Ministries of Health, donors and other stakeholders to develop and manage implementation of large reproductive health, maternal, newborn and child health and HIV projects in many countries in sub-Saharan Africa, as well as in Indonesia. Maryjane holds a Master of Arts degree from University of Maryland and a Bachelor of Arts degree from Loyola University.

Author:

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures

Author:

Susan C. Nicholson, MD, FIDSA

Vice President, Women’s Health
Johnson & Johnson

Susan C. Nicholson, MD, FIDSA

Vice President, Women’s Health
Johnson & Johnson

Author:

Dr. Stephen Gerrard Ph.D.

Independent Expert Advisor Contraception R&D
Contraception R&D

Dr. Stephen Gerrard Ph.D.

Independent Expert Advisor Contraception R&D
Contraception R&D

Author:

Jarrad Aguirre

Head of Strategic Partnerships & Innovation
Myovant Sciences

Jarrad Aguirre, MD, MBA, is Head of Corporate Strategy and Advocacy at Myovant Sciences, a healthcare company focused on women's health and prostate cancer. In this role, he oversees corporate communications, patient advocacy, and digital strategy, and serves on the Executive Committee. 
 
Prior to joining Myovant, Jarrad worked as a physician, researcher, and consultant across the spectrum of health and healthcare, including at Brigham and Women's Hospital (a teaching hospital of Harvard Medical School), The Colorado Health Foundation, the Bill & Melinda Gates Foundation, and Collective Health. 
 
He graduated with honors from Yale University and University of Oxford, where he studied as a Rhodes Scholar. He completed the MD/MBA at Stanford University, supported by the Jack Kent Cooke Foundation Graduate Scholarship.  

Jarrad Aguirre

Head of Strategic Partnerships & Innovation
Myovant Sciences

Jarrad Aguirre, MD, MBA, is Head of Corporate Strategy and Advocacy at Myovant Sciences, a healthcare company focused on women's health and prostate cancer. In this role, he oversees corporate communications, patient advocacy, and digital strategy, and serves on the Executive Committee. 
 
Prior to joining Myovant, Jarrad worked as a physician, researcher, and consultant across the spectrum of health and healthcare, including at Brigham and Women's Hospital (a teaching hospital of Harvard Medical School), The Colorado Health Foundation, the Bill & Melinda Gates Foundation, and Collective Health. 
 
He graduated with honors from Yale University and University of Oxford, where he studied as a Rhodes Scholar. He completed the MD/MBA at Stanford University, supported by the Jack Kent Cooke Foundation Graduate Scholarship.  

Partners

Associate Partner

Event Partner

Media Partners

Early Confirmed Attendees include:

Speakers

 

David Sable

Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Life Sciences Portfolio Manager
Special Situations Funds
 

Barbara Collura

President CEO
RESOLVE

Barbara Collura

President CEO
RESOLVE

Barbara Collura

President CEO
RESOLVE
 

Tom Smith

CEO
Dadi

Tom Smith

CEO
Dadi

Tom Smith

CEO
Dadi
 

Michelle Perugini

CEO & Co-Founder
Presagen

Michelle Perugini

CEO & Co-Founder
Presagen

Michelle Perugini

CEO & Co-Founder
Presagen
 

Arielle Spiegal

Founder & CEO
CoFertility

Arielle is the Founder of CoFertility, a site that aims to un-complicate the fertility journey by answering every fertility question out there. With educational content, resources, and tools, Co provides helpful, digestible information about fertility and reproductive health all in one place—while keeping it real.

 

Prior to founding Co, Arielle led social media and partnerships at Victoria’s Secret PINK and Coach. She thrives on bolstering brand relevance among key audiences, especially when they involve first-to-market technology and media partnerships.

 

Arielle Spiegal

Founder & CEO
CoFertility

Arielle Spiegal

Founder & CEO
CoFertility

Arielle is the Founder of CoFertility, a site that aims to un-complicate the fertility journey by answering every fertility question out there. With educational content, resources, and tools, Co provides helpful, digestible information about fertility and reproductive health all in one place—while keeping it real.

 

Prior to founding Co, Arielle led social media and partnerships at Victoria’s Secret PINK and Coach. She thrives on bolstering brand relevance among key audiences, especially when they involve first-to-market technology and media partnerships.

 

When she’s not busy changing the conversation about fertility, Arielle enjoys hanging out with her husband, Max, and playing with their dog, Oliver. She also loves listening to podcasts, with favorites including NPR’s How I Built This and Big Fat Negative. After multiple rounds of IVF and several losses, Arielle finally had her rainbow baby in June 2020.

 

Mylene Yao

Co-Founder & CEO
Univfy

Mylene Yao

Co-Founder & CEO
Univfy

Mylene Yao

Co-Founder & CEO
Univfy
 

Georgie Kovacs

Founder & CEO
Fempower Health

Georgie Kovacs

Founder & CEO
Fempower Health

Georgie Kovacs

Founder & CEO
Fempower Health
 

Rachel Scherl

Co-Founder & Managing Partner
Spark Solutions

Rachel Scherl

Co-Founder & Managing Partner
Spark Solutions

Rachel Scherl

Co-Founder & Managing Partner
Spark Solutions
 

Anate Brauer

Dr, MD, IVF Director
Shady Grove Fertility - New York

Anate Brauer

Dr, MD, IVF Director
Shady Grove Fertility - New York

Anate Brauer

Dr, MD, IVF Director
Shady Grove Fertility - New York
 

Dr Ranjith Ramasamy

Director of Reproductive Urology
University of Miami

Dr Ranjith Ramasamy

Director of Reproductive Urology
University of Miami

Dr Ranjith Ramasamy

Director of Reproductive Urology
University of Miami
 

Guy Ringler

Reproductive Endocrinologist & Partner
California Fertility Partners

Guy Ringler

Reproductive Endocrinologist & Partner
California Fertility Partners

Guy Ringler

Reproductive Endocrinologist & Partner
California Fertility Partners
 

Anne Morrissey

Former President & CEO
Alydia Health

Anne Morrissey

Former President & CEO
Alydia Health

Anne Morrissey

Former President & CEO
Alydia Health
 

Jenny Yip

Managing Partner
Adjuvant Capital

Jenny Yip

Managing Partner
Adjuvant Capital

Jenny Yip

Managing Partner
Adjuvant Capital
 

Maria Velissaris

Founding Partner
Steel Sky Ventures

Maria Velissaris

Founding Partner
Steel Sky Ventures

Maria Velissaris

Founding Partner
Steel Sky Ventures
 

Kamran Adle

Partner
Octopus Ventures

Kamran Adle

Partner
Octopus Ventures

Kamran Adle

Partner
Octopus Ventures
 

Linda Greub

General Partner
Avestria

Linda Greub

General Partner
Avestria

Linda Greub

General Partner
Avestria
 

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures
 

Shilpa Patel

Chief Business & Legal Officer
KindBody

Shilpa Patel

Chief Business & Legal Officer
KindBody

Shilpa Patel

Chief Business & Legal Officer
KindBody
 

Julia Miller

Healthcare Technology, Marketing Communications Consultant

Julia Miller

Healthcare Technology, Marketing Communications Consultant

Julia Miller

Healthcare Technology, Marketing Communications Consultant
 

Jake Anderson-Bialis

Co-Founder
FertilityIQ

Jake Anderson-Bialis

Co-Founder
FertilityIQ

Jake Anderson-Bialis

Co-Founder
FertilityIQ
 

Lindsey Conon

Group Vice President, Account Management
Progyny

Lindsey Conon

Group Vice President, Account Management
Progyny

Lindsey Conon

Group Vice President, Account Management
Progyny
 

Michele Taylor-Scott, MS, MBA, CCDM,

Head of Data Management
Health Decisions

Michele Taylor-Scott, MS, MBA, CCDM,

Head of Data Management
Health Decisions

Michele Taylor-Scott, MS, MBA, CCDM,

Head of Data Management
Health Decisions
 

Darlene Panzitta

President & Founder
DSP Clinical

Darlene Panzitta

President & Founder
DSP Clinical

Darlene Panzitta

President & Founder
DSP Clinical
 

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio

Evan is the Chief Executive Officer and a Co-Founder of Granata Bio, a US based biopharma company focused on women’s health and fertility.  In his role, Evan is responsible for Granata Bio’s corporate, customer, and commercial strategies.

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio

Evan is the Chief Executive Officer and a Co-Founder of Granata Bio, a US based biopharma company focused on women’s health and fertility.  In his role, Evan is responsible for Granata Bio’s corporate, customer, and commercial strategies.

Before founding Granata Bio, Evan spent nine years at EMD Serono/Merck KgAA.  Most recently, he served as the Marketing and Business Unit Head for the US Fertility/Fertility Technologies businesses.  During this time, Evan spearheaded the creation of innovative programs aimed at expanding access to care for under-recognized patient groups. He has previously served on the corporate council of RESOLVE: The National Infertility Association and the American Society of Reproductive Medicine.

Evan is a graduate of Brown University and received an MBA in Healthcare Leadership from Yale University. He lives in the Boston area with his wife and daughter.

 

Ronald F. Feinberg, M.D., PhD

Founding Partner, Medical Director of IVF Programs
RADFertility

Ronald F. Feinberg, M.D., PhD

Founding Partner, Medical Director of IVF Programs
RADFertility

Ronald F. Feinberg, M.D., PhD

Founding Partner, Medical Director of IVF Programs
RADFertility
 

Marissa Nelson LMFT CST CSE

Founder & CEO
IntimacyIVF

Marissa Nelson LMFT CST CSE

Founder & CEO
IntimacyIVF

Marissa Nelson LMFT CST CSE

Founder & CEO
IntimacyIVF
 

Mikayla Johnson

Vice President Global Solutions
Carrot Fertility

Mikayla Johnson

Vice President Global Solutions
Carrot Fertility

Mikayla Johnson

Vice President Global Solutions
Carrot Fertility

Fertility Innovation Spotlight

Do you have an innovation in fertility that you would like to share with the Fertility Innovation Summit? Be one of 6 finalists, selected by our prestigious selection committee, showcase their innovations to our audience and get priority access to our meeting platform.

We are looking for solutions such as: 

  • Therapeutic Technology
  • Hormone Testing Product
  • Fertility/Ovulation Tracking Technology
  • Medical Device
  • Fertility – Drug solution
  • Telehealth Solution
  • IVF Supporting technology
  • Lab supporting technology
  • Patient support product
  • Genetic Screening Technology

What happens if I apply? 

All applications will be considered by our selection committee which includes Adjuvent Capital, Avestria, Steel Sky Ventures, Rhia Ventures and Octopus Ventures. 

If you are successful and are named on of the 6 finalists, showcase your innovation to the entire Fertility Innovation Summit with a 3 minute video and gain additional exposure on the virtual platform. 

SUBMISSION DEADLINE:  MARCH 16, 2021

APPLY NOW

1
Day
30+
Industry Leading Speakers
4+
Dedicated Networking Hours
5+
In-depth Case Studies
100+
Industry Executives

WOMEN'S HEALTH INNOVATION SERIES 2021 CALENDAR

dates.png

DOWNLOAD AGENDA

Download the 2021 Fertility Innovation Summit Agenda to discover the speaker and topics we will be covering at the event this year!

Fill your details below

TICKET PACKAGES

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Preparing registration...

RESOURCES

Download Resource

The Virtual Experience

Top 10 benefits

- Tailor Your Agenda 

- More Audience Participation

- Improved Audience Visibility 

- On-Demand Content

- High Quality Speakers 

- More Networking Opportunities 

- Save Time & Money 

- Increased Content 

- More insights 

- Business Development Opportunities - Talk to our team to find out out more [email protected].

Platform Preview

Interested in a Press Pass?

If you're interested in a press pass or would like to learn about media partnership opportunities, please contact [email protected]

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us